万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002082 万邦德

交易中 08-16 11:15:51

{"stockData":{"symbol":"002082","market":"SZ","secType":"STK","nameCN":"万邦德","latestPrice":4.45,"timestamp":1723778151000,"preClose":4.44,"halted":0,"volume":2816801,"delay":0,"floatShares":617000000,"shares":617000000,"eps":0.0823,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"08-16 11:15:51","open":4.5,"high":4.5,"low":4.38,"amount":12487500,"amplitude":0.027,"askPrice":4.46,"askSize":299,"bidPrice":4.45,"bidSize":172,"shortable":0,"etf":0,"ttmEps":0.0823,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1723779000000},"adr":0,"adjPreClose":4.44,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":4.88,"lowLimit":4,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":616689055,"pbRate":1.02,"roa":"--","roe":"1.08%","epsLYR":0.08,"committee":-0.569707,"marketValue":2744000000,"floatMarketCap":2744000000,"peRate":54.070474,"changeRate":0.0023,"turnoverRate":0.0046,"status":0},"requestUrl":"/m/hq/s/002082","defaultTab":"news","newsList":[{"id":"2459294299","title":"万邦德（002082）8月13日主力资金净卖出149.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459294299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459294299?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:24","pubTimestamp":1723533892,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，万邦德报收于4.52元，下跌1.53%，换手率1.42%，成交量8.78万手，成交额3939.69万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。万邦德主营业务：医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0050","BK0004","BK0028","BK0239","002082"],"gpt_icon":0},{"id":"2458893549","title":"万邦德最新公告：子公司康慈医疗签订5390.72万元国有土地上房屋收购补偿协议书","url":"https://stock-news.laohu8.com/highlight/detail?id=2458893549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458893549?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:01","pubTimestamp":1723471276,"startTime":"0","endTime":"0","summary":"万邦德公告，子公司康慈医疗拟与山海建设签订《国有土地上房屋收购补偿协议书》，因江山市江贺经济走廊土地有机更新和整治提升需要，康慈医疗位于江山市江山经济开发区山海协作区汇源路20号的土地、建筑及附属物、设施设备等被征收，共计可获得补偿奖励款为人民币5390.72万元，补偿方式为货币补偿。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200032843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","159891","BK0004","BK0050","BK0239","002082"],"gpt_icon":0},{"id":"2455989188","title":"万邦德：感谢您的指正，由于排版过程的失误给投资者造成了不好的阅读体验，深表歉意","url":"https://stock-news.laohu8.com/highlight/detail?id=2455989188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455989188?lang=zh_cn&edition=full","pubTime":"2024-07-31 18:00","pubTimestamp":1722420057,"startTime":"0","endTime":"0","summary":"感谢您的指正，由于排版过程的失误给投资者造成了不好的阅读体验，深表歉意。为提高投资者对定期报告的阅读体验，公司将不断优化排版格式及图表呈现，同时进一步加强信息披露文件的细节把控。公司致力于为全球患者带来更好的临床获益，美国FDA的孤儿药以及罕见儿科疾病相关认定，为产品的国际化开发奠定了良好的法规注册基础。目前FDA新药物申请正常推进中，尚未开始临床试验环节。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100038470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0004","BK0028","002082","BK0050"],"gpt_icon":0},{"id":"2452752511","title":"万邦德（002082）7月18日主力资金净买入39.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452752511","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452752511?lang=zh_cn&edition=full","pubTime":"2024-07-18 15:27","pubTimestamp":1721287632,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月18日收盘，万邦德报收于4.15元，下跌2.35%，换手率1.39%，成交量8.59万手，成交额3544.89万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。万邦德主营业务：医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800027263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0050","BK0239","002082","BK0028"],"gpt_icon":0},{"id":"2452918610","title":"万邦德（002082）7月17日主力资金净买入327.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452918610","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452918610?lang=zh_cn&edition=full","pubTime":"2024-07-17 15:21","pubTimestamp":1721200895,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月17日收盘，万邦德报收于4.25元，上涨2.66%，换手率0.99%，成交量6.13万手，成交额2583.29万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。万邦德主营业务：医药制造、医疗器械大健康产业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700026494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002082","BK0239","BK0004","BK0028","BK0050"],"gpt_icon":0},{"id":"2450846096","title":"万邦德（002082）7月9日主力资金净买入59.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450846096","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450846096?lang=zh_cn&edition=full","pubTime":"2024-07-09 15:26","pubTimestamp":1720509981,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月9日收盘，万邦德报收于4.13元，下跌0.96%，换手率0.77%，成交量4.73万手，成交额1944.96万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。万邦德主营业务：医药制造、医疗器械大健康产业。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070900027055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002082","BK0004","BK0028","BK0050"],"gpt_icon":0},{"id":"2448940448","title":"【万邦德(002082.SZ)2023年度权益分派：每10股派0.8元】智通财经APP讯，万邦德(002082.SZ)发布公告，公司2023年年度权益分派方案为：以公司现有总股本剔除已回购股份后为基数，向全体股东每10股派0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448940448","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448940448?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:47","pubTimestamp":1720086452,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0004","BK0239","002082","BK0028","BK0050"],"gpt_icon":0},{"id":"2448448149","title":"万邦德(002082.SZ)2023年度权益分派：每10股派0.8元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448448149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448448149?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:47","pubTimestamp":1720086452,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德(002082.SZ)发布公告，公司2023年年度权益分派方案为：以公司现有总股本剔除已回购股份后为基数，向全体股东每10股派0.8元人民币现金(含税)，本次权益分派股权登记日为：2024年7月10日，除权除息日为：2024年7月11日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1145666.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0050","BK0239","BK0028","002082","BK0004"],"gpt_icon":0},{"id":"2448448169","title":"万邦德最新公告：2023年度权益分派10派0.8元 股权登记日7月10日","url":"https://stock-news.laohu8.com/highlight/detail?id=2448448169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448448169?lang=zh_cn&edition=full","pubTime":"2024-07-04 17:39","pubTimestamp":1720085989,"startTime":"0","endTime":"0","summary":"万邦德公布2023年年度权益分派实施公告，公司2023年年度权益分派方案为：以公司现有总股本剔除已回购股份5,000,000股后的611,689,055股为基数，向全体股东每10股派0.8元人民币现金(含税)。本次权益分派股权登记日为：2024年7月10日，除权除息日为：2024年7月11日。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400034980.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0050","BK0004","BK0028","BK0239","002082"],"gpt_icon":0},{"id":"2439546716","title":"【万邦德(002082.SZ)：石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定】智通财经APP讯，万邦德(002082.","url":"https://stock-news.laohu8.com/highlight/detail?id=2439546716","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439546716?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:17","pubTimestamp":1716977851,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0028","BK0239","BK1191","HIE","BK1574","BK0050","BK0004","002082","01477"],"gpt_icon":0},{"id":"2439462415","title":"万邦德(002082.SZ)：石杉碱甲治疗新生儿缺氧缺血性脑病适应症获美国FDA孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2439462415","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439462415?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:17","pubTimestamp":1716977851,"startTime":"0","endTime":"0","summary":"本次石杉碱甲治疗新生儿缺氧缺血性脑病适应症获得FDA孤儿药资格认定，是继石杉碱甲用于重症肌无力获得FDA孤儿药资格认定，及治疗新生儿缺氧缺血性脑病适应症获得FDA“罕见儿科疾病”药物资格认定后的又一重要进展，本次认定将有助于加快公司药品国际化战略布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1127780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","BK0004","BK0050","002082"],"gpt_icon":0},{"id":"2439654684","title":"万邦德：子公司产品石杉碱甲获得美国FDA孤儿药认定。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439654684","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439654684?lang=zh_cn&edition=full","pubTime":"2024-05-29 18:10","pubTimestamp":1716977421,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0004","BK0239","002082","BK0028","BK0050"],"gpt_icon":0},{"id":"2437808930","title":"万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437808930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437808930?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:06","pubTimestamp":1716548767,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德(002082.SZ)公告，公司实际控制人之一、董事长、总经理赵守明增持股份计划实施完毕，其累计增持公司股份732.69万股，占公司现有总股本的1.1881%，增持金额为3277.98万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1125946.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002082","BK0050","BK0004","BK0239","BK0028"],"gpt_icon":0},{"id":"2437708088","title":"【万邦德(002082.SZ)实控人之一赵守明完成增持 累计增持732.69万股】智通财经APP讯，万邦德(002082.","url":"https://stock-news.laohu8.com/highlight/detail?id=2437708088","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437708088?lang=zh_cn&edition=full","pubTime":"2024-05-24 19:06","pubTimestamp":1716548767,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0239","BK0004","BK0028","002082","BK0050"],"gpt_icon":0},{"id":"2434679930","title":"【万邦德(002082.SZ)董事长累计增持1.19%股份】智通财经APP讯，万邦德(002082.SZ)发布公告，截至2024年5月8日，本次增持计划时间已过半。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434679930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434679930?lang=zh_cn&edition=full","pubTime":"2024-05-09 18:33","pubTimestamp":1715250836,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0028","BK0050","002082","BK0004","BK0239","399001"],"gpt_icon":0},{"id":"2434441067","title":"万邦德(002082.SZ)董事长累计增持1.19%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2434441067","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434441067?lang=zh_cn&edition=full","pubTime":"2024-05-09 18:33","pubTimestamp":1715250836,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德(002082.SZ)发布公告，截至2024年5月8日，本次增持计划时间已过半。公司实际控制人之一、董事长、总经理赵守明已通过深圳证券交易所集中竞价交易的方式累计增持公司股份732.69万股，占公司现有总股本的1.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1119402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0004","BK0028","002082","BK0239","BK0050"],"gpt_icon":0},{"id":"2433713953","title":"万邦德（002082）5月8日主力资金净买入350.72万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433713953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433713953?lang=zh_cn&edition=full","pubTime":"2024-05-08 15:21","pubTimestamp":1715152916,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月8日收盘，万邦德报收于5.25元，上涨2.14%，换手率1.47%，成交量9.09万手，成交额4740.38万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：万邦德2024年一季报显示，公司主营收入4.29亿元，同比上升11.41%；归母净利润2883.85万元，同比上升5.49%；扣非净利润1409.73万元，同比下降43.19%；负债率36.73%，投资收益22.86万元，财务费用1115.1万元，毛利率36.17%。万邦德主营业务：医药制造、医疗器械大健康产业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800021286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","BK0050","BK0028","BK0239","002082"],"gpt_icon":0},{"id":"2433622891","title":"万邦德(002082.SZ)：石杉碱甲获美国FDA罕见儿科疾病药物认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2433622891","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433622891?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:23","pubTimestamp":1715070235,"startTime":"0","endTime":"0","summary":"智通财经APP讯，万邦德 发布公告，公司全资子公司万邦德制药集团有限公司于2024年5月1日收到美国食品药品监督管理局的认定函，石杉碱甲用于治疗新生儿缺氧缺血性脑病获得FDA授予的“罕见儿科疾病”药物认定。据悉，新生儿HIE是由脑组织缺氧和脑血流量减少引起的一种新生儿脑损伤疾病，目前治疗方式包括支持疗法、控制惊厥、治疗脑水肿、亚低温治疗等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0004","BK0050","BK0028","BK0239","002082"],"gpt_icon":0},{"id":"2433228994","title":"【万邦德(002082.SZ)：石杉碱甲获美国FDA罕见儿科疾病药物认定】智通财经APP讯，万邦德(002082.SZ)发布公告，公司全资子公司万邦德制药集团有限公司于2024年5月1日收到美国食品药品监督管理局(简称“FDA”)的认定函，石杉碱甲用于治疗新生儿缺氧缺血性脑病(HIE)获得FDA授予的“罕见儿科疾病”(Rare Pediatric Disease,RPD)药物认定。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433228994","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433228994?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:23","pubTimestamp":1715070235,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0004","HIE","LU1878469433.USD","BK0050","BK0028","BK1191","BK4097","BK0239","002082","RPD","BK1574","01477"],"gpt_icon":0},{"id":"2433240923","title":"万邦德：子公司产品石杉碱甲获得美国FDA罕见儿科疾病药物认定。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433240923","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433240923?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:16","pubTimestamp":1715069814,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK0004","002082","BK0239","BK0050","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2006-11-20","address":"浙江省湖州市吴兴区织里镇栋梁路1688号","stockEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":0.0725},{"period":"3month","weight":-0.1138},{"period":"6month","weight":0.0681},{"period":"1year","weight":-0.3586},{"period":"ytd","weight":-0.2924}],"companyName":"万邦德医药控股集团股份有限公司","boardCode":"AI0027","perCapita":"33079股","boardName":"医药制造业","registeredCapital":"61668万元","compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0332},{"period":"3month","weight":-0.0877},{"period":"6month","weight":0.004},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.0328}],"survey":"　　万邦德医药控股集团股份有限公司主营业务为现代中药、化学原料药及化学制剂的研发、生产和销售以及提供高端医疗器械研制、医疗设备服务和提供医院工程服务。主要产品是心脑血管系统主导产品、神经系统主导产品、呼吸系统主导产品、消化系统主导产品、精神系统主导产品、骨科植入器械、医疗设备及医院工程服务、一次性无菌医用高分子耗材、防护用品。","serverTime":1723778154312,"listedPrice":6.36,"stockholders":"167174人(较上一季度增加441.61%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦德(002082)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦德,002082,万邦德股票,万邦德股票老虎,万邦德股票老虎国际,万邦德行情,万邦德股票行情,万邦德股价,万邦德股市,万邦德股票价格,万邦德股票交易,万邦德股票购买,万邦德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦德(002082)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦德(002082)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}